ChartRow logo
ChartRow
Stocks and ETFs
Sign in
REGN
Regeneron Pharmaceuticals Inc.Stock · Healthcare
$654.27+$29.55 (+4.73%)as of market close, Jul 2, 2026
CompareLLYUNHJNJABBVMRKABT

How Regeneron Pharmaceuticals uses its cash

Fiscal year

Where does Regeneron Pharmaceuticals's cash go? This Sankey traces cash from net income through operating cash flow into capex, free cash flow, dividends, buybacks, and debt paydown. Pick any fiscal year. Straight from SEC filings.

Regeneron Pharmaceuticals Inc. · FY2025 · year ended 2025-12-31
Operating cash flow$5.0BCash from operations$6.0B · 121%Net income$4.5B · 90%D&A$544M · 11%Stock comp$994M · 20%Working capital$1.1B · 21%Free cash flow$4.1B · 82%Capex$898M · 18%Dividends$370M · 7%Buybacks$3.4B · 69%Cash retained$272M · 5%

Each fiscal year from SEC filings. Percentages are share of operating cash flow. Sources (net income + non-cash add-backs) flow into operating cash flow, which splits into capex and free cash flow; free cash flow goes to dividends, buybacks, debt paydown, and what's retained. Annual only. For informational purposes only.